140 related articles for article (PubMed ID: 16135655)
1. Olanzapine and weight gain.
Isaac MB; Isaac MT
Am J Psychiatry; 2005 Sep; 162(9):1764-5; author reply 1765. PubMed ID: 16135655
[No Abstract] [Full Text] [Related]
2. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine.
Gothelf D; Falk B; Singer P; Kairi M; Phillip M; Zigel L; Poraz I; Frishman S; Constantini N; Zalsman G; Weizman A; Apter A
Am J Psychiatry; 2002 Jun; 159(6):1055-7. PubMed ID: 12042200
[TBL] [Abstract][Full Text] [Related]
3. Is olanzapine a brain-sparing medication?
Joober R; Schmitz N; Malla A; Sengupta S; Karma S
Arch Gen Psychiatry; 2006 Nov; 63(11):1292. PubMed ID: 17088510
[No Abstract] [Full Text] [Related]
4. Aripiprazole improves metabolic adversity in olanzapine-treated schizophrenic patients.
Chen CH; Huang MC; Lu ML
J Clin Psychopharmacol; 2007 Oct; 27(5):516-7. PubMed ID: 17873689
[No Abstract] [Full Text] [Related]
5. What is the mechanism for aripiprazole's effect on reducing olanzapine-associated obesity?
Deng C; Chen J; Hu C; Huang XF
J Clin Psychopharmacol; 2010 Aug; 30(4):480-1. PubMed ID: 20631576
[No Abstract] [Full Text] [Related]
6. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of antipsychotic-induced weight gain.
McIntyre RS; Mancini DA; Basile VS
J Clin Psychiatry; 2001; 62 Suppl 23():23-9. PubMed ID: 11603882
[TBL] [Abstract][Full Text] [Related]
8. Profiling of energy metabolism in olanzapine-induced weight gain in rats and its prevention by the CB1-antagonist AVE1625.
Liebig M; Gossel M; Pratt J; Black M; Haschke G; Elvert R; Juretschke HP; Neumann-Haefelin C; Kramer W; Herling AW
Obesity (Silver Spring); 2010 Oct; 18(10):1952-8. PubMed ID: 20168311
[TBL] [Abstract][Full Text] [Related]
9. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
[TBL] [Abstract][Full Text] [Related]
10. Hypertriglyceridemia associated with direct effects of olanzapine rather than with weight gain: a case report.
Markham-Abedi C; de Leon J
J Clin Psychiatry; 2006 Sep; 67(9):1473-4. PubMed ID: 17017841
[No Abstract] [Full Text] [Related]
11. Antipsychotic drugs and schizophrenia.
Duan N; Kraemer HC; Mintz J
N Engl J Med; 2006 Jan; 354(3):298-300; author reply 298-300. PubMed ID: 16422019
[No Abstract] [Full Text] [Related]
12. Olanzapine and pediatric bipolar disorder: evidence for efficacy and safety concerns.
McClellan JM
Am J Psychiatry; 2007 Oct; 164(10):1462-4. PubMed ID: 17898331
[No Abstract] [Full Text] [Related]
13. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
[TBL] [Abstract][Full Text] [Related]
14. Ethical concerns regarding olanzapine versus placebo in patients prodromally symptomatic for psychosis.
Block JJ
Am J Psychiatry; 2006 Oct; 163(10):1838; author reply 1838. PubMed ID: 17012701
[No Abstract] [Full Text] [Related]
15. Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats.
Raskind MA; Burke BL; Crites NJ; Tapp AM; Rasmussen DD
Neuropsychopharmacology; 2007 Feb; 32(2):284-8. PubMed ID: 16710316
[TBL] [Abstract][Full Text] [Related]
16. Bofu-tsusho-san effectively attenuates the weight gain observed after receiving olanzapine.
Yamamoto N; Inada T
Psychiatry Clin Neurosci; 2008 Dec; 62(6):747. PubMed ID: 19068015
[No Abstract] [Full Text] [Related]
17. A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.
Henderson DC; Copeland PM; Daley TB; Borba CP; Cather C; Nguyen DD; Louie PM; Evins AE; Freudenreich O; Hayden D; Goff DC
Am J Psychiatry; 2005 May; 162(5):954-62. PubMed ID: 15863798
[TBL] [Abstract][Full Text] [Related]
18. Metformin plus sibutramine for olanzapine-associated weight gain and metabolic dysfunction in schizophrenia: a 12-week double-blind, placebo-controlled pilot study.
Baptista T; Uzcátegui E; Rangel N; El Fakih Y; Galeazzi T; Beaulieu S; de Baptista EA
Psychiatry Res; 2008 May; 159(1-2):250-3. PubMed ID: 18374423
[TBL] [Abstract][Full Text] [Related]
19. Orally disintegrating olanzapine and potential differences in treatment-emergent weight gain.
Karagianis J; Hoffmann VP; Arranz B; Treuer T; Maguire GA; de Haan L; Chawla B
Hum Psychopharmacol; 2008 Jun; 23(4):275-81. PubMed ID: 18338426
[TBL] [Abstract][Full Text] [Related]
20. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
Saddichha S; Ameen S; Akhtar S
J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
